Cargando…
Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
The prodrug nifurtimox has been used for more than 40 years to treat Chagas disease and forms part of a recently approved combinational therapy that targets West African trypanosomiasis. Despite this, its mode of action is poorly understood. Detection of reactive oxygen and nitrogen intermediates in...
Autores principales: | Hall, Belinda S., Bot, Christopher, Wilkinson, Shane R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075655/ https://www.ncbi.nlm.nih.gov/pubmed/21345801 http://dx.doi.org/10.1074/jbc.M111.230847 |
Ejemplares similares
-
Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
por: Baker, Nicola, et al.
Publicado: (2011) -
Megazol and its bioisostere 4H-1,2,4-triazole: comparing
the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico
interactions with the Trypanosoma brucei nitroreductase
enzyme
por: de Carvalho, Alcione Silva, et al.
Publicado: (2014) -
Metabolites From Trypanosome-Infected Cattle as Sensitive Biomarkers for Animal Trypanosomosis
por: Getahun, Merid N., et al.
Publicado: (2022) -
The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood–brain barrier: Evidence for involvement of breast cancer resistance protein
por: Watson, Christopher P., et al.
Publicado: (2012) -
The Role of Nitroreductases in Resistance to Nitroimidazoles
por: Thomas, Carol, et al.
Publicado: (2021)